Barstow Craig, Kassop David
Womack Army Medical Center Department of the Army, WAMC Stop A 2817 Reilly Rd, Ft Bragg, NC 28310-7301.
FP Essent. 2019 Apr;479:16-20.
Chronic venous insufficiency (CVI) results from long-term venous hypertension in the legs caused by venous obstruction, venous valve incompetency, muscle pump dysfunction, or a combination of these. CVI occurs in 9.4% of men and 6.6% of women. It takes any of several forms, including leg pain and heaviness, leg edema that is worsened by prolonged standing and relieved by elevation, stasis dermatitis, skin fibrosis, skin ulcers, and varicose veins. If the patient history and/or physical examination results are suggestive of CVI, the diagnosis can be confirmed with duplex ultrasonography. The primary conservative treatment is use of compression stockings. Physical therapy and exercise programs often are recommended but little evidence supports their use. If a skin ulcer is present, appropriate wound care is indicated. Flavonoid drugs have been shown to improve venous function but none are approved for use in the United States. Diosmiplex, a flavonoid medical food product derived from oranges, is approved by the Food and Drug Administration for management of CVI and has shown some benefits. Patients with more severe manifestations of CVI should be referred to a vascular subspecialist for consideration of interventional therapies.
慢性静脉功能不全(CVI)是由静脉阻塞、静脉瓣膜功能不全、肌肉泵功能障碍或这些因素的组合导致腿部长期静脉高压引起的。CVI在9.4%的男性和6.6%的女性中发生。它有几种形式,包括腿部疼痛和沉重感、长时间站立会加重且抬高后缓解的腿部水肿、淤积性皮炎、皮肤纤维化、皮肤溃疡和静脉曲张。如果患者病史和/或体格检查结果提示CVI,可通过双功超声检查确诊。主要的保守治疗方法是使用弹力袜。通常推荐物理治疗和运动计划,但几乎没有证据支持其使用。如果存在皮肤溃疡,则需要进行适当的伤口护理。类黄酮药物已被证明可改善静脉功能,但在美国均未获批准使用。地奥司明,一种源自橙子的类黄酮医用食品,已获美国食品药品监督管理局批准用于治疗CVI,并已显示出一些益处。CVI表现较严重的患者应转诊至血管专科医生处考虑进行介入治疗。